Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.85 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.85 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.85 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.85 |
| ▸ | MEN1 | O00255 | 4/20 | 0.85 |
| ▸ | USP2 | O75604 | 4/20 | 0.85 |
| ▸ | TSHR | P16473 | 3/20 | 0.85 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.85 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.85 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.85 |
| ▸ | THRB | P10828 | 2/20 | 0.85 |
| ▸ | HPN | P05981 | 1/20 | 0.85 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.85 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.85 |
| ▸ | PDE4A | P27815 | 1/20 | 0.85 |
| ▸ | KDR | P35968 | 1/20 | 0.85 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.85 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.85 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.85 |
| ▸ | TNF | P01375 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Anthralin SCHEMBL30013383 | 0.92 | MAPT (1.00) | MAPTKMT2AALDH1A1TDP1MEN1 | |
| Anthralin SCHEMBL29439039 | 0.92 | MAPT (1.00) | MAPTKMT2AALDH1A1TDP1MEN1 | |
| Anthralin SCHEMBL3197 | 0.92 | MAPT (1.00) | MAPTKMT2AALDH1A1TDP1MEN1 | |
| Anthralin SCHEMBL7555831 | 0.90 | MAPT (0.96) | MAPTKMT2AALDH1A1TDP1MEN1 | |
| Anthralin SCHEMBL5555097 | 0.81 | MAPT (0.71) | MAPTKMT2AALDH1A1TDP1MEN1 | |
| SCHEMBL29549838 | 0.79 | MAPT (0.75) | MAPTKMT2AALDH1A1TDP1MEN1 | |
| SCHEMBL1204733 | 0.79 | MAPT (0.75) | MAPTKMT2AALDH1A1TDP1MEN1 | |
| SCHEMBL12023167 | 0.79 | ALDH1A1 (0.74) | MAPTKMT2AALDH1A1TDP1MEN1 | |
| SCHEMBL11208428 | 0.78 | MAPT (0.66) | MAPTKMT2AALDH1A1TDP1MEN1 | |
| SCHEMBL31509436 | 0.78 | ALDH1A1 (0.71) | MAPTKMT2AALDH1A1TDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2402307-B1 | HYDROGELLING AGENT | RITSUMEIKAN TRUST (JP) | 2016-12-21 | — | — | EP | disclosed |
| US-8633022-B2 | Dual-terminal amide hydrogelling agent | THE RITSUMEIKAN TRUST (JP) | 2014-01-21 | — | — | US | disclosed |
| EP-2402307-A1 | DUAL-TERMINAL AMIDE HYDROGELLING AGENT | The Ritsumeikan Trust (JP) | 2012-01-04 | — | — | EP | disclosed |
| US-20110312092-A1 | DUAL-TERMINAL AMIDE HYDROGELLING AGENT | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2011-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110312092-A1 | DUAL-TERMINAL AMIDE HYDROGELLING AGENT | H1-2, H1-0, H1-4 | MAPT 3665/4885KMT2A 446/4885ALDH1A1 195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.